 | • レポートコード：GIR-107A12365 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、イブルチニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。イブルチニブの種類別市場規模（5mg、10mg、140mg）、用途別市場規模（マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・イブルチニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie (Pharmacyclics)、Johnson & Johnson (Janssen Biotech)、SP Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：5mg、10mg、140mg ・用途別分析2016年-2026年：マントル細胞リンパ腫、慢性リンパ性白血病、ワルデンストレームマクログロブリン血症、再発/難治性辺縁帯リンパ腫、慢性移植片対宿主病 ・イブルチニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・イブルチニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・イブルチニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イブルチニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・イブルチニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Imbruvica market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Imbruvica size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Imbruvica market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Imbruvica market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg
10 mg
140 mg
Market segment by Application, can be divided into
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström’s Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease
Market segment by players, this report covers
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Imbruvica product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Imbruvica, with revenue, gross margin and global market share of Imbruvica from 2019 to 2021.
Chapter 3, the Imbruvica competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Imbruvica market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Imbruvica research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Imbruvica
1.2 Classification of Imbruvica by Type
1.2.1 Overview: Global Imbruvica Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Imbruvica Revenue Market Share by Type in 2020
1.2.3 5 mg
1.2.4 10 mg
1.2.5 140 mg
1.3 Global Imbruvica Market by Application
1.3.1 Overview: Global Imbruvica Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Waldenström’s Macroglobulinemia
1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Global Imbruvica Market Size & Forecast
1.5 Global Imbruvica Market Size and Forecast by Region
1.5.1 Global Imbruvica Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Imbruvica Market Size by Region, (2016-2021)
1.5.3 North America Imbruvica Market Size and Prospect (2016-2026)
1.5.4 Europe Imbruvica Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Imbruvica Market Size and Prospect (2016-2026)
1.5.6 South America Imbruvica Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Imbruvica Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Imbruvica Market Drivers
1.6.2 Imbruvica Market Restraints
1.6.3 Imbruvica Trends Analysis
2 Company Profiles
2.1 AbbVie (Pharmacyclics)
2.1.1 AbbVie (Pharmacyclics) Details
2.1.2 AbbVie (Pharmacyclics) Major Business
2.1.3 AbbVie (Pharmacyclics) Imbruvica Product and Solutions
2.1.4 AbbVie (Pharmacyclics) Imbruvica Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie (Pharmacyclics) Recent Developments and Future Plans
2.2 Johnson & Johnson (Janssen Biotech)
2.2.1 Johnson & Johnson (Janssen Biotech) Details
2.2.2 Johnson & Johnson (Janssen Biotech) Major Business
2.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Product and Solutions
2.2.4 Johnson & Johnson (Janssen Biotech) Imbruvica Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson (Janssen Biotech) Recent Developments and Future Plans
2.3 SP Laboratories
2.3.1 SP Laboratories Details
2.3.2 SP Laboratories Major Business
2.3.3 SP Laboratories Imbruvica Product and Solutions
2.3.4 SP Laboratories Imbruvica Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 SP Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Imbruvica Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Imbruvica Players Market Share
3.2.2 Top 10 Imbruvica Players Market Share
3.2.3 Market Competition Trend
3.3 Imbruvica Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Imbruvica Revenue and Market Share by Type (2016-2021)
4.2 Global Imbruvica Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Imbruvica Revenue Market Share by Application (2016-2021)
5.2 Imbruvica Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Imbruvica Revenue by Type (2016-2026)
6.2 North America Imbruvica Revenue by Application (2016-2026)
6.3 North America Imbruvica Market Size by Country
6.3.1 North America Imbruvica Revenue by Country (2016-2026)
6.3.2 United States Imbruvica Market Size and Forecast (2016-2026)
6.3.3 Canada Imbruvica Market Size and Forecast (2016-2026)
6.3.4 Mexico Imbruvica Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Imbruvica Revenue by Type (2016-2026)
7.2 Europe Imbruvica Revenue by Application (2016-2026)
7.3 Europe Imbruvica Market Size by Country
7.3.1 Europe Imbruvica Revenue by Country (2016-2026)
7.3.2 Germany Imbruvica Market Size and Forecast (2016-2026)
7.3.3 France Imbruvica Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Imbruvica Market Size and Forecast (2016-2026)
7.3.5 Russia Imbruvica Market Size and Forecast (2016-2026)
7.3.6 Italy Imbruvica Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Imbruvica Revenue by Type (2016-2026)
8.2 Asia-Pacific Imbruvica Revenue by Application (2016-2026)
8.3 Asia-Pacific Imbruvica Market Size by Region
8.3.1 Asia-Pacific Imbruvica Revenue by Region (2016-2026)
8.3.2 China Imbruvica Market Size and Forecast (2016-2026)
8.3.3 Japan Imbruvica Market Size and Forecast (2016-2026)
8.3.4 South Korea Imbruvica Market Size and Forecast (2016-2026)
8.3.5 India Imbruvica Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Imbruvica Market Size and Forecast (2016-2026)
8.3.7 Australia Imbruvica Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Imbruvica Revenue by Type (2016-2026)
9.2 South America Imbruvica Revenue by Application (2016-2026)
9.3 South America Imbruvica Market Size by Country
9.3.1 South America Imbruvica Revenue by Country (2016-2026)
9.3.2 Brazil Imbruvica Market Size and Forecast (2016-2026)
9.3.3 Argentina Imbruvica Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Imbruvica Revenue by Type (2016-2026)
10.2 Middle East & Africa Imbruvica Revenue by Application (2016-2026)
10.3 Middle East & Africa Imbruvica Market Size by Country
10.3.1 Middle East & Africa Imbruvica Revenue by Country (2016-2026)
10.3.2 Turkey Imbruvica Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Imbruvica Market Size and Forecast (2016-2026)
10.3.4 UAE Imbruvica Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Imbruvica Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Imbruvica Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Imbruvica Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Imbruvica Revenue (USD Million) by Region (2016-2021)
Table 5. Global Imbruvica Revenue Market Share by Region (2021-2026)
Table 6. AbbVie (Pharmacyclics) Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie (Pharmacyclics) Major Business
Table 8. AbbVie (Pharmacyclics) Imbruvica Product and Solutions
Table 9. AbbVie (Pharmacyclics) Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson (Janssen Biotech) Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson (Janssen Biotech) Major Business
Table 12. Johnson & Johnson (Janssen Biotech) Imbruvica Product and Solutions
Table 13. Johnson & Johnson (Janssen Biotech) Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. SP Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. SP Laboratories Major Business
Table 16. SP Laboratories Imbruvica Product and Solutions
Table 17. SP Laboratories Imbruvica Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global Imbruvica Revenue (USD Million) by Players (2019-2021)
Table 19. Global Imbruvica Revenue Share by Players (2019-2021)
Table 20. Breakdown of Imbruvica by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Imbruvica Players Head Office, Products and Services Provided
Table 22. Imbruvica Mergers & Acquisitions in the Past Five Years
Table 23. Imbruvica New Entrants and Expansion Plans
Table 24. Global Imbruvica Revenue (USD Million) by Type (2016-2021)
Table 25. Global Imbruvica Revenue Share by Type (2016-2021)
Table 26. Global Imbruvica Revenue Forecast by Type (2021-2026)
Table 27. Global Imbruvica Revenue by Application (2016-2021)
Table 28. Global Imbruvica Revenue Forecast by Application (2021-2026)
Table 29. North America Imbruvica Revenue by Type (2016-2021) & (USD Million)
Table 30. North America Imbruvica Revenue by Type (2021-2026) & (USD Million)
Table 31. North America Imbruvica Revenue by Application (2016-2021) & (USD Million)
Table 32. North America Imbruvica Revenue by Application (2021-2026) & (USD Million)
Table 33. North America Imbruvica Revenue by Country (2016-2021) & (USD Million)
Table 34. North America Imbruvica Revenue by Country (2021-2026) & (USD Million)
Table 35. Europe Imbruvica Revenue by Type (2016-2021) & (USD Million)
Table 36. Europe Imbruvica Revenue by Type (2021-2026) & (USD Million)
Table 37. Europe Imbruvica Revenue by Application (2016-2021) & (USD Million)
Table 38. Europe Imbruvica Revenue by Application (2021-2026) & (USD Million)
Table 39. Europe Imbruvica Revenue by Country (2016-2021) & (USD Million)
Table 40. Europe Imbruvica Revenue by Country (2021-2026) & (USD Million)
Table 41. Asia-Pacific Imbruvica Revenue by Type (2016-2021) & (USD Million)
Table 42. Asia-Pacific Imbruvica Revenue by Type (2021-2026) & (USD Million)
Table 43. Asia-Pacific Imbruvica Revenue by Application (2016-2021) & (USD Million)
Table 44. Asia-Pacific Imbruvica Revenue by Application (2021-2026) & (USD Million)
Table 45. Asia-Pacific Imbruvica Revenue by Region (2016-2021) & (USD Million)
Table 46. Asia-Pacific Imbruvica Revenue by Region (2021-2026) & (USD Million)
Table 47. South America Imbruvica Revenue by Type (2016-2021) & (USD Million)
Table 48. South America Imbruvica Revenue by Type (2021-2026) & (USD Million)
Table 49. South America Imbruvica Revenue by Application (2016-2021) & (USD Million)
Table 50. South America Imbruvica Revenue by Application (2021-2026) & (USD Million)
Table 51. South America Imbruvica Revenue by Country (2016-2021) & (USD Million)
Table 52. South America Imbruvica Revenue by Country (2021-2026) & (USD Million)
Table 53. Middle East & Africa Imbruvica Revenue by Type (2016-2021) & (USD Million)
Table 54. Middle East & Africa Imbruvica Revenue by Type (2021-2026) & (USD Million)
Table 55. Middle East & Africa Imbruvica Revenue by Application (2016-2021) & (USD Million)
Table 56. Middle East & Africa Imbruvica Revenue by Application (2021-2026) & (USD Million)
Table 57. Middle East & Africa Imbruvica Revenue by Country (2016-2021) & (USD Million)
Table 58. Middle East & Africa Imbruvica Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Imbruvica Picture
Figure 2. Global Imbruvica Revenue Market Share by Type in 2020
Figure 3. 5 mg
Figure 4. 10 mg
Figure 5. 140 mg
Figure 6. Imbruvica Revenue Market Share by Application in 2020
Figure 7. Mantle Cell Lymphoma Picture
Figure 8. Chronic Lymphocytic Leukemia Picture
Figure 9. Waldenström's Macroglobulinemia Picture
Figure 10. Relapsed/Refractory Marginal Zone Lymphoma Picture
Figure 11. Chronic Graft-Versus-Host-Disease Picture
Figure 12. Global Imbruvica Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Imbruvica Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Imbruvica Revenue Market Share by Region (2016-2026)
Figure 15. Global Imbruvica Revenue Market Share by Region in 2020
Figure 16. North America Imbruvica Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Imbruvica Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Imbruvica Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Imbruvica Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Imbruvica Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Imbruvica Market Drivers
Figure 22. Imbruvica Market Restraints
Figure 23. Imbruvica Market Trends
Figure 24. AbbVie (Pharmacyclics) Recent Developments and Future Plans
Figure 25. Johnson & Johnson (Janssen Biotech) Recent Developments and Future Plans
Figure 26. SP Laboratories Recent Developments and Future Plans
Figure 27. Global Imbruvica Revenue Share by Players in 2020
Figure 28. Imbruvica Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Imbruvica Revenue Market Share in 2020
Figure 30. Global Top 10 Players Imbruvica Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Imbruvica Revenue Share by Type in 2020
Figure 33. Global Imbruvica Market Share Forecast by Type (2021-2026)
Figure 34. Global Imbruvica Revenue Share by Application in 2020
Figure 35. Global Imbruvica Market Share Forecast by Application (2021-2026)
Figure 36. North America Imbruvica Sales Market Share by Type (2016-2026)
Figure 37. North America Imbruvica Sales Market Share by Application (2016-2026)
Figure 38. North America Imbruvica Revenue Market Share by Country (2016-2026)
Figure 39. United States Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Imbruvica Sales Market Share by Type (2016-2026)
Figure 43. Europe Imbruvica Sales Market Share by Application (2016-2026)
Figure 44. Europe Imbruvica Revenue Market Share by Country (2016-2026)
Figure 45. Germany Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Imbruvica Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Imbruvica Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Imbruvica Revenue Market Share by Region (2016-2026)
Figure 53. China Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Imbruvica Sales Market Share by Type (2016-2026)
Figure 60. South America Imbruvica Sales Market Share by Application (2016-2026)
Figure 61. South America Imbruvica Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Imbruvica Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Imbruvica Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Imbruvica Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Imbruvica Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
世界のB細胞慢性リンパ性白血病治療市場 2021：企業別、地域別、種類・用途別 The B-Cell Chronic Lymphocytic Leukemia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- 世界の慢性リンパ性白血病（CLL）治療市場予測（～2024年） Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for treating (for example, which symptoms it is causing). Scope of the Report: The global Chronic Lymphocytic Leukemia (CLL) Treatment market is valued at xx m…
- B細胞リンパ腫2阻害剤の世界市場 2019年版：種類別（併用療法、単剤療法）、用途別（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病 ） Scope of the Report: The global B-cell lymphoma 2 Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…
- 世界の血液がん用遺伝子改変免疫療法市場 2021：企業別、地域別、種類・用途別 The Gene Modifying Immunotherapy for Blood Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のホジキンリンパ腫治療薬市場 2021：企業別、地域別、種類・用途別 The Hodgkin's Lymphoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…